Pharma's Holy Grail: The next Alzheimer's drug
September 05, 2013 at 14:30 PM EDT
After more than two decades of research, a treatment that slows or actually reverses the progression of Alzheimer's has proved elusive, in part because no one has pinpointed the cause of the disease.